Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deep Sharma

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Gut|November 27, 2019
Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cellsZhen Dai, Guangqi Song, Asha Balakrishnan, et al.
Science Advances|April 9, 2025
Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I diseaseTaihua Yang, Jiahao Ge, Lei Huang, et al.
Cell Stem Cell|March 1, 2016
Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver FibrosisGuangqi Song, Martin Pacher, Asha Balakrishnan, et al.
Elife|February 5, 2026
Ly6G<sup>+</sup> granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesisPriya Sharma, Raman Deep Sharma, Binayak Sarkar, et al.
EMBO Molecular Medicine|June 25, 2020
Innovations, challenges, and minimal information for standardization of humanized miceRenata Stripecke, Christian Münz, Jan Jacob Schuringa, et al.
Cell Reports|May 7, 2016
Small Molecules Facilitate Single Factor-Mediated Hepatic ReprogrammingKyung Tae Lim, Seung Chan Lee, Yimeng Gao, et al.
Journal of Hepatology|August 28, 2021
Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical modelTaihua Yang, Marion Poenisch, Rajendra Khanal, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 26, 2021
Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ RegenerationFrank Arnold, Pallavi U Mahaddalkar, Johann M Kraus, et al.
Cell Discovery|November 5, 2025
Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trialKang He, Xue-Jing Zhu, Yao-Ping Shi, et al.
Zoological Research|March 30, 2023
Cell atlas of CCl <sub>4</sub>-induced progressive liver fibrosis reveals stage-specific responsesPeng-Cheng Guo, Jing Zuo, Ke-Ke Huang, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Gut|November 27, 2019
Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cellsZhen Dai, Guangqi Song, Asha Balakrishnan, et al.
Science Advances|April 9, 2025
Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I diseaseTaihua Yang, Jiahao Ge, Lei Huang, et al.
Cell Stem Cell|March 1, 2016
Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver FibrosisGuangqi Song, Martin Pacher, Asha Balakrishnan, et al.
Elife|February 5, 2026
Ly6G<sup>+</sup> granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesisPriya Sharma, Raman Deep Sharma, Binayak Sarkar, et al.
EMBO Molecular Medicine|June 25, 2020
Innovations, challenges, and minimal information for standardization of humanized miceRenata Stripecke, Christian Münz, Jan Jacob Schuringa, et al.
Cell Reports|May 7, 2016
Small Molecules Facilitate Single Factor-Mediated Hepatic ReprogrammingKyung Tae Lim, Seung Chan Lee, Yimeng Gao, et al.
Journal of Hepatology|August 28, 2021
Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical modelTaihua Yang, Marion Poenisch, Rajendra Khanal, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 26, 2021
Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ RegenerationFrank Arnold, Pallavi U Mahaddalkar, Johann M Kraus, et al.
Cell Discovery|November 5, 2025
Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trialKang He, Xue-Jing Zhu, Yao-Ping Shi, et al.
Zoological Research|March 30, 2023
Cell atlas of CCl <sub>4</sub>-induced progressive liver fibrosis reveals stage-specific responsesPeng-Cheng Guo, Jing Zuo, Ke-Ke Huang, et al.
Pageof 12